back to news

Immunarray Gets Investment From Another Firm For Traumatic Brain Injury Research


By John Reid Blackwell

ImmunArray, a molecular diagnostics company with an office in the Virginia Biotechnology Research Park in Richmond, said Wednesday it has received an investment from another firm that will advance its work in traumatic head injury research.

The investment comes from Quanterix Corp., a Lexington, Mass.-based company that has developed highly sensitive technology for analysis of biomarkers in the blood, such as those that occur from a head injury.

The deal gives ImmunArray access to that technology and enables the companies to work together on methods for detecting mild to moderate traumatic brain injury.

Read the remainder of the article Richmond Times-Dispatch.